Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Strata Critical Medical (SRTA) EBT (2019 - 2025)

Strata Critical Medical (SRTA) has disclosed EBT for 7 consecutive years, with -$5.4 million as the latest value for Q4 2025.

  • Quarterly EBT rose 27.48% to -$5.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$22.3 million through Dec 2025, up 22.24% year-over-year, with the annual reading at -$20.1 million for FY2025, 24.16% down from the prior year.
  • EBT for Q4 2025 was -$5.4 million at Strata Critical Medical, up from -$9.7 million in the prior quarter.
  • The five-year high for EBT was $8.4 million in Q2 2022, with the low at -$35.0 million in Q4 2023.
  • Average EBT over 5 years is -$7.9 million, with a median of -$7.6 million recorded in 2021.
  • The sharpest move saw EBT tumbled 102528.1% in 2021, then skyrocketed 208.25% in 2022.
  • Over 5 years, EBT stood at $663000.0 in 2021, then plummeted by 2549.92% to -$16.2 million in 2022, then plummeted by 115.26% to -$35.0 million in 2023, then soared by 78.75% to -$7.4 million in 2024, then grew by 27.48% to -$5.4 million in 2025.
  • According to Business Quant data, EBT over the past three periods came in at -$5.4 million, -$9.7 million, and -$3.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.